Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EP9598 / 2||LA / OT|
Administered by: Other Purchased by: ??
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data:
CDC 'Split Type': NOPFIZER INC2021730516
Write-up: ABORTION; This is a spontaneous report from a contactable other hcp downloaded from the European Medicines Agency (EMA) EudraVigilance-WEB, regulatory authority number NO-NOMAADVRE-FHI-2021-U2m959. A 35-years-old female patient received second dose of BNT162B2 (COMIRNATY, Formulation: Solution for Injection, Batch/Lot number: EP9598) via intramuscularly, administered in left arm on 03Mar2021 at 09:30 as single dose for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, Lot number: unknown) on 10Feb2021 for covid-19 immunisation. The patient took a pregnancy test that confirmed she was pregnant on 14Apr2021. Conception was 1-2 weeks earlier. Gestation period was 3-4 weeks. Two days later she had a miscarriage. The outcome of the event was resolved. No follow-up attempts possible. No further information expected. Lot/Batch number already obtained. ; Reporter''s Comments: Reporter type: Ambulance worker No more information available
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166